<DOC>
	<DOCNO>NCT01081288</DOCNO>
	<brief_summary>Nationwide cluster-randomised trial extend NHS breast screening age range England</brief_summary>
	<brief_title>Extending National Health Service ( NHS ) Breast Screening Age Range</brief_title>
	<detailed_description>In 1988 , national Breast Screening Programme ( BSP ) begin offer woman age 50-64 year triennial mammographic screen full national coverage achieve mid-1990s . In 2003 , age range triennial screening extend 50-64 50-70 year ; proposal committees Department Health randomise age extension thereby obtain reliable information risk benefit additional screening age 65-70 adopt . Currently , 80 breast screen unit cover England , responsible defined area , year invite 2.8 million woman age 50-70 , 2.0 million accepting . The BSP set standard screen unit monitor performance national quality assurance network . In 2007 , Prime Minister announce plan eventual extension range 47-73 year . This offer another opportunity obtain reliable evidence effect extend age range triennial screening . Hence , trial age extension begin , half offer extra screening , effect monitor routinely collect NHS statistic . Following 2009-10 pilot study acceptability cluster-randomisation additional screening age 47-49 71-73 5 breast screen unit , AgeX trial extend recruitment five-sixths breast screening clinic England , cluster-randomisation continue . In 2011 , Government defer early possible date screening would extend woman age 47-73 . Later , Public Health England ( PHE , responsible government screen programme ) state final decision extension age range would await emergence reliable evidence effect . The AgeX trial eventually provide . In 2012 , independent panel set Department Health charity Cancer Research UK report `` The UK breast screen programme [ age 50-70 ] confer significant benefit continue… . The impact breast screen outside age 50-69 year uncertain . The Panel support principle ongoing trial UK [ AgeX ] randomise woman age 50 age 70 invite breast screening '' . Meanwhile , female life expectancy increase , interest grow possible advantage continue screen woman early 70 throughout 70 . The advantage disadvantage continue triennial screening age 70 would see clearly trial 2 3 additional invitation ( cover age 71-76 71-79 ) trial one . In 2013 All-Party Parliamentary Group Breast Cancer Older Women ( APPG ) say `` Women routinely invite breast screening past age 70 … current 'age extension trial ' [ screen past age 70 ] … extend past 73 76 , , appropriate … extend '' . In separate report 2015 APPG reiterate conclusion . Although AgeX begin trial additional screening age 47-49 age 71-73 , therefore become trial old woman allocate additional screening , resource available , continue invite triennially age 71-76 age 71-79 , thereby assess effect continue triennial screening several year age 70 .</detailed_description>
	<criteria>Female , Aged 4749 year 7173 year , In Breast Screening Unit participate study . ( All Breast Screening Units England expect participate study exception use nonstandard method create screen batch ) . Anyone satisfy inclusion criterion</criteria>
	<gender>Female</gender>
	<minimum_age>47 Years</minimum_age>
	<maximum_age>73 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Breast screen</keyword>
	<keyword>Mammography</keyword>
	<keyword>Routine screening programme</keyword>
</DOC>